U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H4N4O2
Molecular Weight 152.1109
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of XANTHINE

SMILES

O=C1NC2=C(NC=N2)C(=O)N1

InChI

InChIKey=LRFVTYWOQMYALW-UHFFFAOYSA-N
InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)

HIDE SMILES / InChI

Molecular Formula C5H4N4O2
Molecular Weight 152.1109
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues.
2001-07-06
Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation.
2001-05-05
Miniaturized amperometric biosensor based on xanthine oxidase for monitoring hypoxanthine in cell culture media.
2001-05-01
Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
2001-05
Xanthine oxidase inhibitory activity of selected Australian native plants.
2001-05
Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia.
2001-04-27
Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.
2001-04-20
Effects of tocopheryl quinone on the heart: model experiments with xanthine oxidase, heart mitochondria, and isolated perfused rat hearts.
2001-04-15
Insight into the chemistry of flavin reduction and oxidation in Escherichia coli dihydroorotate dehydrogenase obtained by rapid reaction studies.
2001-04-10
Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors.
2001-04-09
Effect of poly ICLC treatment on hepatic oxidative stress and antioxidant defense indices in Plasmodium yoelii nigeriensis infected mice.
2001-04-05
Reactive oxygen species (ROS)-generating oxidases in the normal rabbit cornea and their involvement in the corneal damage evoked by UVB rays.
2001-04
Photoreactivation of alloxanthine-inhibited xanthine oxidase.
2001-04
Abnormal Ca2+ signalling in vascular endothelial cells from spontaneously hypertensive rats: role of free radicals.
2001-04
Serum xanthine oxidase in human liver disease.
2001-04
Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants.
2001-04
Properties of tomato powders as additives for food fortification and stabilization.
2001-04
Analysis of peroxynitrite reactions with guanine, xanthine, and adenine nucleosides by high-pressure liquid chromatography with electrochemical detection: C8-nitration and -oxidation.
2001-04
Effect of reactive oxygen species on fetal lung maturation.
2001-04
Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis.
2001-04
Functional characterization of a maize purine transporter by expression in Aspergillus nidulans.
2001-04
The chemical work of Alexander and Jane Marcet.
2001-04
Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia.
2001-04
The effects of delta sleep-inducing peptide on the intensity of lipid peroxidation and xanthine oxidase activity in rat tissues during cold stress.
2001-03-27
Cytochrome C is a potent catalyst of dichlorofluorescin oxidation: implications for the role of reactive oxygen species in apoptosis.
2001-03-23
Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells.
2001-03-15
Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells.
2001-03-15
Enhancement of antioxidant and anti-inflammatory activities of bioflavonoid rutin by complexation with transition metals.
2001-03-15
Astrocytes overexpressing Cu,Zn superoxide dismutase have increased resistance to oxidative injury.
2001-03-15
Asafoetida inhibits early events of carcinogenesis: a chemopreventive study.
2001-03-09
ESR studies on reaction of saccharide with the free radicals generated from the xanthine oxidase/hypoxanthine system containing iron.
2001-03-09
Cytosolic xanthine oxidoreductase mediated bioactivation of ethanol to acetaldehyde and free radicals in rat breast tissue. Its potential role in alcohol-promoted mammary cancer.
2001-03-07
Tautomeric energetics of xanthine oxidase substrates: xanthine, 2-oxo-6-methylpurine, and lumazine.
2001-03
The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and alpha1-blockers.
2001-03
Antagonism of free-radical-induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells.
2001-03
Molecular cloning of a cDNA coding for feline liver xanthine dehydrogenase.
2001-03
Inhibition of xanthine and monoamine oxidases by stilbenoids from Veratrum taliense.
2001-03
Aryl hydrocarbon receptor (AhR)-mediated induction of xanthine oxidase/xanthine dehydrogenase activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
2001-03
A simple technique for the simultaneous determination of molecular weight and activity of superoxide dismutase using SDS-PAGE.
2001-02-26
Effects of L-arginine cardioplegia on myocardium.
2001-02
Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol.
2001-02
Caffeine metabolism before and after liver transplantation.
2001-02
Evaluation of health aspects of kojic acid in food.
2001-02
Characterization of DNA damage at purine residues in oligonucleotides and calf thymus DNA induced by the mutagen 1-nitrosoindole-3-acetonitrile.
2001-02
Cerebral ischemia in humans after traumatic brain injury.
2001-02
Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury.
2001-02
Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome.
2001-01
Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn.
2001
Free radicals and brain damage in the newborn.
2001
Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:48:43 GMT 2025
Edited
by admin
on Mon Mar 31 17:48:43 GMT 2025
Record UNII
1AVZ07U9S7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
XANTHINE
INCI   MI   WHO-DD  
INCI  
Official Name English
NSC-14664
Preferred Name English
9H-PURINE-2,6(1H,3H)-DIONE
Systematic Name English
XANTHIC OXIDE
Common Name English
3,9-DIHYDRO-1H-PURINE-2,6-DIONE
Systematic Name English
1H,3H,9H-XANTHINE
Common Name English
1H-PURINE-2,6-DIOL
Systematic Name English
3,9-DIHYDROPURINE-2,6-DIONE
Systematic Name English
Xanthine [WHO-DD]
Common Name English
1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-
Systematic Name English
2,6-DIOXO-1,2,3,6-TETRAHYDROPURINE
Systematic Name English
2,6-DIOXOPURINE
Systematic Name English
XANTHINE [MI]
Common Name English
1H,3H,7H-XANTHINE
Common Name English
PURINE-2,6(1H,3H)-DIONE
Systematic Name English
1H-PURINE-2,6-DIONE, 3,9-DIHYDRO-
Systematic Name English
Classification Tree Code System Code
LOINC 41227-0
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 75144-6
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 38371-1
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 75129-7
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 3131-0
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 3132-8
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 41230-4
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
EPA PESTICIDE CODE 116900
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 72897-2
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 41228-8
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
LOINC 58036-5
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
Code System Code Type Description
MESH
D019820
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
EVMPD
SUB15733MIG
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
PUBCHEM
1188
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
FDA UNII
1AVZ07U9S7
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
RXCUI
1311085
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY RxNorm
SMS_ID
100000076747
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
WIKIPEDIA
XANTHINE
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
DAILYMED
1AVZ07U9S7
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
NSC
14664
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
CHEBI
48517
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID4035120
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
CAS
69-89-6
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-718-6
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
CHEBI
17712
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
DRUG BANK
DB02134
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
MERCK INDEX
m11527
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY Merck Index
CHEBI
15318
Created by admin on Mon Mar 31 17:48:43 GMT 2025 , Edited by admin on Mon Mar 31 17:48:43 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
METABOLITE -> PARENT
PARENT -> METABOLITE
MINOR
Related Record Type Details
ACTIVE MOIETY